SDF-1 signaling: A promising target in rheumatic diseases

Expert Opinion on Therapeutic Targets

Volumn 18, Issue 9, 2014, Pages 1077-1087

  Villalvilla, Amanda ^a   Gomez, Rodolfo ^b   Roman Blas, Jorge A ^a   Largo, Raquel ^a   Herrero Beaumont, Gabriel ^a  

^a UAM)   (Spain)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Bone; Cartilage; Chondrocyte; CXCL12; CXCR4; CXCR7; Osteoarthritis; Osteoclast; Rheumatoid arthritis; Stromal cell derived factor 1; Synoviocyte; Synovium

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; CYTOKINE; STROMAL CELL DERIVED FACTOR 1; ANTIRHEUMATIC AGENT; CHEMOKINE RECEPTOR CXCR; CXCR7 PROTEIN, HUMAN;

BONE EROSION; BONE TURNOVER; CARTILAGE DEGENERATION; DISEASE COURSE; HUMAN; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVITIS; ANIMAL; ANTAGONISTS AND INHIBITORS; ARTHRITIS, RHEUMATOID; DRUG DESIGN; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHEMOKINE CXCL12; DRUG DESIGN; HUMANS; MOLECULAR TARGETED THERAPY; OSTEOARTHRITIS; RECEPTORS, CXCR; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION;

EID: 84906264129     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2014.930440     Document Type: Review

References (110)

1. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/ SDF-1. Nature 1996;382(6592):635-8
2. Aiuti A, Webb IJ, Bleul C, et al. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997;185(1):111-20
3. Cho SY, Xu M, Roboz J, et al. The effect of CXCL12 processing on CD34+ cell migration in myeloproliferative neoplasms. Cancer Res 2010;70(8):3402-10
4. Staudt ND, Maurer A, Spring B, et al. Processing of CXCL12 by different osteoblast-secreted cathepsins. Stem Cells Dev 2012;21(11):1924-35
5. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10(8):858-64
6. Kortesidis A, Zannettino A, Isenmann S, et al. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 2005;105(10):3793-801
7. Abbott JD, Huang Y, Liu D, et al. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004;110(21):3300-5
8. Villalvilla A, Moro M, Arruza L, et al. Circulating endothelial progenitor cells are reduced in rat oxygen-induced retinopathy despite a retinal SDF-1/CXCR4 and VEGF proangiogenic response. Life Sci 2012;91(7-8):264-70
9. Kitaori T, Ito H, Schwarz EM, et al. Stromal cell-derived factor 1/ CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 2009;60(3):813-23
10. Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005;121(3):335-48
11. Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996;382(6594):833-5
12. Bleul C, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV- 1 entry. Nature 1996;382(6594):829-33
13. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seventransmembrane, G protein-coupled receptor. Science 1996;272(5263):872-7
14. Kucia M, Reca R, Miekus K, et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005;23(7):879-94
15. Gao H, Priebe W, Glod J, Banerjee D. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium. Stem Cells 2009;27(4):857-65
16. Lu DY, Tang CH, Yeh WL, et al. SDF-1alpha up-regulates interleukin- 6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia. Eur J Pharmacol 2009;613(1-3):146-54
17. Wang JF, Park IW, Groopman JE. Stromal cell-derived factor-1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C. Blood 2000;95(8):2505-13
18. Zhang XF, Wang JF, Matczak E, et al. Janus kinase 2 is involved in stromal cellderived factor-1alpha-induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells. Blood 2001;97(11):3342-8
19. Massa A, Casagrande S, Bajetto A, et al. SDF-1 controls pituitary cell proliferation through the activation of ERK1/2 and the Ca2+-dependent, cytosolic tyrosine kinase Pyk2. Ann NY Acad Sci 2006;1090:385-98
20. Lataillade JJ, Clay D, Bourin P, et al. Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. Blood 2002;99(4):1117-29
21. Paunovic V, Harnett MM. Mitogen-activated protein kinases as therapeutic targets for rheumatoid arthritis. Drugs 2013;73(2):101-15
22. Saklatvala J. Inflammatory signaling in cartilage: MAPK and NF-kappaB pathways in chondrocytes and the use of inhibitors for research into pathogenesis and therapy of osteoarthritis. Curr Drug Targets 2007;8(2):305-13
23. Petit I, Goichberg P, Spiegel A, et al. Atypical PKC-zeta regulates SDF-1-mediated migration and development of human CD34+ progenitor cells. J Clin Invest 2005;115(1):168-76
24. Henschler R, Piiper A, Bistrian R, Möbest D. SDF-1alpha-induced intracellular calcium transient involves Rho GTPase signalling and is required for migration of hematopoietic progenitor cells. Biochem Biophys Res Commun 2003;311(4):1067-71
25. Munk R, Ghosh P, Ghosh MC, et al. Involvement of mTOR in CXCL12 mediated T cell signaling and migration. PLoS One 2011;6(9):e24667
26. Sun Y, Cheng Z, Ma L, Pei G. Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J Biol Chem 2002;277(51):49212-19
27. Saini V, Marchese A, Majetschak M. CXC chemokine receptor 4 is a cell surface receptor for extracellular ubiquitin. J Biol Chem 2010;285(20):15566-76
28. Saini V, Staren DM, Ziarek JJ, et al. The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor- 1alpha; function through distinct receptor interactions. J Biol Chem 2011;286(38):33466-77
29. Majetschak M. Extracellular ubiquitin: immune modulator and endogenous opponent of damage-associated molecular pattern molecules. J Leukoc Biol 2011;89(2):205-19
30. Steagall RJ, Daniels CR, Dalal S, et al. Extracellular ubiquitin increases expression of angiogenic molecules and stimulates angiogenesis in cardiac microvascular endothelial cells. Microcirculation 2014;21(4):324-32
31. Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 2012;64(6):1697-707
32. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365(23):2205-19
33. Takada K, Hirose J, Senba K, et al. Enhanced apoptotic and reduced protective response in chondrocytes following endoplasmic reticulum stress in osteoarthritic cartilage. Int J Exp Pathol 2011;92(4):232-42
34. Balabanian K, Lagane B, Infantino S, et al. The chemokine SDF-1/ CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 2005;280(42):35760-6
35. Boldajipour B, Mahabaleshwar H, Kardash E, et al. Control of chemokineguided cell migration by ligand sequestration. Cell 2008;132(3):463-73
36. Dai X, Tan Y, Cai S, et al. The role of CXCR7 on the adhesion, proliferation and angiogenesis of endothelial progenitor cells. J Cell Mol Med 2011;15(6):1299-309
37. Zabel BA, Wang Y, Lewén S, et al. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol 2009;183(5):3204-11
38. Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 2006;203(9):2201-13
39. Décaillot FM, Kazmi MA, Lin Y, et al. CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration. J Biol Chem 2011;286(37):32188-97
40. Levoye A, Balabanian K, Baleux F, et al. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 2009;113(24):6085-93
41. Wei L, Kanbe K, Lee M, et al. Stimulation of chondrocyte hypertrophy by chemokine stromal cell-derived factor 1 in the chondro-osseous junction during endochondral bone formation. Dev Biol 2010;341(1):236-45
42. Jones SW, Brockbank SM V, Mobbs ML, et al. The orphan G-protein coupled receptor RDC1: evidence for a role in chondrocyte hypertrophy and articular cartilage matrix turnover. Osteoarthritis Cartilage 2006;14(6):597-608
43. García-Vicuña R, Gómez-Gaviro MV, Domínguez-Luis MJ, et al. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Rheum 2004;50(12):3866-77
44. Watanabe K, Penfold MET, Matsuda A, et al. Pathogenic role of CXCR7 in rheumatoid arthritis. Arthritis Rheum 2010;62(11):3211-20
45. Kanbe K, Takagishi K, Chen Q. Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum 2002;46(1):130-7
46. Pablos JL, Santiago B, Galindo M, et al. Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immunol 2003;170(4):2147-52
47. Grassi F, Cristino S, Toneguzzi S, et al. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. J Cell Physiol 2004;199(2):244-51
48. Van Oosterhout M, Bajema I, Levarht EWN, et al. Differences in synovial tissue infiltrates between anticyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis Rheum 2008;58(1):53-60
49. Joven B, González N, Aguilar F, et al. Association between stromal cell-derived factor 1 chemokine gene variant and radiographic progression of rheumatoid arthritis. Arthritis Rheum 2005;52(1):354-6
50. Mittal GA, Joshi VR, Deshpande A. Stromal cell-derived factor-1 alpha in rheumatoid arthritis. Rheumatology (Oxford) 2003;42(7):915-16
51. Hansen IB, Ellingsen T, Hornung N, et al. Plasma level of CXC-chemokine CXCL12 is increased in rheumatoid arthritis and is independent of disease activity and methotrexate treatment. J Rheumatol 2006;33(9):1754-9
52. Kanbe K, Takemura T, Takeuchi K, et al. Synovectomy reduces stromal-cell-derived factor-1 (SDF-1) which is involved in the destruction of cartilage in osteoarthritis and rheumatoid arthritis. J Bone Joint Surg Br 2004;86(2):296-300
53. Van Oosterhout M, Levarht EWN, Sont JK, et al. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12. Ann Rheum Dis 2005;64(4):537-43
54. Nanki T, Hayashida K, El-Gabalawy HS, et al. Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol 2000;165(11):6590-8
55. Henneken M, D̈orner T, Burmester GR, Berek C. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther 2005;7(5):R1001-13
56. Bryant J, Ahern DJ, Brennan FM. CXCR4 and vascular cell adhesion molecule 1 are key chemokine/adhesion receptors in the migration of cytokineactivated T cells. Arthritis Rheum 2012;64(7):2137-46
57. Buckley CD, Amft N, Bradfield PF, et al. Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol 2000;165(6):3423-9
58. Rodríguez-Carrio J, Alperi-López M, López P, et al. Angiogenic T cells are decreased in rheumatoid arthritis patients. Ann Rheum Dis 2014. [Epub ahead of print]
59. Bradfield PF, Amft N, Vernon-Wilson E, et al. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue. Arthritis Rheum 2003;48(9):2472-82
60. Burman A, Haworth O, Hardie DL, et al. A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis. J Immunol 2005;174(3):1693-700
61. Santiago B, Calonge E, Del Rey MJ, et al. CXCL12 gene expression is upregulated by hypoxia and growth arrest but not by inflammatory cytokines in rheumatoid synovial fibroblasts. Cytokine 2011;53(2):184-90
62. Hitchon C, Wong K, Ma G, et al. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum 2002;46(10):2587-97
63. Ogura N, Tobe M, Sakamaki H, et al. Tumor necrosis factor-alpha increases chemokine gene expression and production in synovial fibroblasts from human temporomandibular joint. J Oral Pathol Med 2005;34(6):357-63
64. Nanki T, Nagasaka K, Hayashida K, et al. Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Immunol 2001;167(9):5381-5
65. Kim KW, Cho ML, Kim HR, et al. Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction. Arthritis Rheum 2007;56(4):1076-86
66. Amin MA, Mansfield PJ, Pakozdi A, et al. Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways. Arthritis Rheum 2007;56(6):1787-97
67. Hot A, Zrioual S, Lenief V, Miossec P. IL-17 and tumour necrosis factor alpha combination induces a HIF-1alpha-dependent invasive phenotype in synoviocytes. Ann Rheum Dis 2012;71(8):1393-401
68. Chen HT, Tsou HK, Hsu CJ, et al. Stromal cell-derived factor-1/ CXCR4 promotes IL-6 production in human synovial fibroblasts. J Cell Biochem 2011;112(4):1219-27
69. Wei L, Sun X, Kanbe K, et al. Chondrocyte death induced by pathological concentration of chemokine stromal cell-derived factor-1. J Rheumatol 2006;33(9):1818-26
70. Yu X, Huang Y, Collin-Osdoby P, Osdoby P. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration. J bone Miner Res 2003;18(8):1404-18
71. De Klerck B, Geboes L, Hatse S, et al. Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis. Arthritis Res Ther 2005;7(6):R1208-20
72. Wright LM, Maloney W, Yu X, et al. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts. Bone 2005;36(5):840-53
73. Van den Brand BT, Abdollahi-Roodsaz S, Bennink MB, et al. Toll-like receptor 4 in bone marrowderived cells as well as tissue-resident cells participate in aggravating autoimmune destructive arthritis. Ann Rheum Dis 2013;72(8):1407-15
74. Xing Q, de Vos P, Faas MM, et al. LPS promotes pre-osteoclast activity by upregulating CXCR4 via TLR-4. J Dent Res 2011;90(2):157-62
75. Kim HR, Kim KW, Kim BM, et al. Reciprocal activation of CD4+ T Cells and synovial fibroblasts by stromal cellderived factor 1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis. Arthritis Rheumatol 2014;66(3):538-48
76. Matthys P, Hatse S, Vermeire K, et al. AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice. J Immunol 2001;167(8):4686-92
77. Tamamura H, Fujisawa M, Hiramatsu K, et al. Identification of a CXCR4 antagonist, a T140 analog, as an anti-rheumatoid arthritis agent. FEBS Lett 2004;569(1-3):99-104
78. Haas CS, Martinez RJ, Attia N, et al. Chemokine receptor expression in rat adjuvant-induced arthritis. Arthritis Rheum 2005;52(12):3718-30
79. Del Rey MJ, Izquierdo E, Caja S, et al. Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxiainducible transcription factor 1alpha/ vascular endothelial growth factor-mediated pathway in immunodeficient mice. Arthritis Rheum 2009;60(10):2926-34
80. Blades MC, Ingegnoli F, Wheller SK, et al. Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice. Arthritis Rheum 2002;46(3):824-36
81. Van der Kraan PM, van den Berg WB. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? Osteoarthritis Cartilage 2011;20(3):223-32
82. Karouzakis E, Rengel Y, Jüngel A, et al. DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes Immun 2011;12(8):643-52
83. Xu Q, Sun X-C, Shang X-P, Jiang H-S. Association of CXCL12 levels in synovial fluid with the radiographic severity of knee osteoarthritis. J Investig Med 2012;60(6):898-901
84. Mazzetti I, Magagnoli G, Paoletti S, et al. A role for chemokines in the induction of chondrocyte phenotype modulation. Arthritis Rheum 2004;50(1):112-22
85. Cristino S, Piacentini A, Manferdini C, et al. Expression of CXC chemokines and their receptors is modulated during chondrogenic differentiation of human mesenchymal stem cells grown in threedimensional scaffold: evidence in native cartilage. Tissue Eng Part A 2008;14(1):97-105
86. Miyaki S, Nakasa T, Otsuki S, et al. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin- 1 responses. Arthritis Rheum 2009;60(9):2723-30
87. Nicolas FE, Pais H, Schwach F, et al. Experimental identification of microRNA-140 targets by silencing and overexpressing miR-140. RNA 2008;14(12):2513-20
88. Appleton CTG, Pitelka V, Henry J, Beier F. Global analyses of gene expression in early experimental osteoarthritis. Arthritis Rheum 2007;56(6):1854-68
89. Lisignoli G, Cristino S, Piacentini A, et al. Hyaluronan-based polymer scaffold modulates the expression of inflammatory and degradative factors in mesenchymal stem cells: involvement of Cd44 and Cd54. J Cell Physiol 2006;207(2):364-73
90. Wei F, Moore DC, Li Y, et al. Attenuation of osteoarthritis via blockade of the SDF-1/CXCR4 signaling pathway. Arthritis Res Ther 2012;14(4):R177
91. Mendelson A, Frank E, Allred C, et al. Chondrogenesis by chemotactic homing of synovium, bone marrow, and adipose stem cells in vitro. FASEB J 2011;25(10):3496-504
92. Guang LG, Boskey AL, Zhu W. Regulatory role of stromal cell-derived factor-1 in bone morphogenetic protein-2-induced chondrogenic differentiation in vitro. Int J Biochem Cell Biol 2012;44(11):1825-33
93. Shen W, Chen J, Zhu T, et al. Intra-articular injection of human meniscus stem/progenitor cells promotes meniscus regeneration and ameliorates osteoarthritis through stromal cell-derived factor-1/CXCR4-mediated homing. Stem Cells Transl Med 2014;3(3):387-94
94. Lisignoli G, Toneguzzi S, Piacentini A, et al. CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients. J Cell Physiol 2006;206(1):78-85
95. Volin M V, Koch AE. Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis. J Interferon Cytokine Res 2011;31(10):745-51
96. Melchionna R, Porcelli D,Mangoni A, et al. Laminar shear stress inhibits CXCR4 expression on endothelial cells: functional consequences for atherogenesis. FASEB J 2005;19(6):629-31
97. Leucht P, Temiyasathit S, Russell A, et al. CXCR4 antagonism attenuates load-induced periosteal bone formation in mice. J Orthop Res 2013;31(11):1828-38
98. Visigalli D, Strangio A, Palmieri D, Manduca P. Hind limb unloading of mice modulates gene expression at the protein and mRNA level in mesenchymal bone cells. BMC Musculoskelet Disord 2010;11(1):147
99. Xia WH, Yang Z, Xu SY, et al. Age-Related Decline in Reendothelialization Capacity of Human Endothelial Progenitor Cells Is Restored by Shear Stress. Hypertension 2012;59(6):1225-31
100. Herrero-Beaumont G, Roman-Blas JA, Castañeda S, Jimenez SA. Primary osteoarthritis no longer primary: three subsets with distinct etiological, clinical, and therapeutic characteristics. Semin Arthritis Rheum 2009;39(2):71-80
101. Fricker SP. Physiology and pharmacology of plerixafor. Transfus Med Hemother 2013;40(4):237-45
102. Kalatskaya I, Berchiche YA, Gravel S, et al. AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol Pharmacol 2009;75(5):1240-7
103. Debnath B, Xu S, Grande F, et al. Small molecule inhibitors of CXCR4. Theranostics 2013;3(1):47-75
104. Cojoc M, Peitzsch C, Trautmann F, et al. Emerging targets in cancer management: role of the CXCL12/ CXCR4 axis. Onco Targets Ther 2013;6:1347-61
105. Peled A, Abraham M, Avivi I, et al. The high-affinity CXCR4 antagonist BKT140 is safe and induces a robust mobilization of human CD34+ cells in patients with multiple myeloma. Clin Cancer Res 2014;20(2):469-79
106. Zhang WB, Navenot JM, Haribabu B, et al. A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists. J Biol Chem 2002;277(27):24515- 21
107. Hao M, Zheng J, Hou K, et al. Role of chemokine receptor CXCR7 in bladder cancer progression. Biochem Pharmacol 2012;84(2):204-14
108. Li X, Zhu M, Penfold ME, et al. Activation of CXCR7 limits atherosclerosis and improves hyperlipidemia by increasing cholesterol uptake in adipose tissue. Circulation 2014;129(11):1244-53
109. Sartina E, Suguihara C, Ramchandran S, et al. Antagonism of CXCR7 attenuates chronic hypoxia-induced pulmonary hypertension. Pediatr Res 2012;71(6):682-8
110. Walters MJ, Ebsworth K, Berahovich RD, et al. Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats. Br J Cancer 2014;110(5):1179-88